About US
Contact us
-
Merck CEO calls on private industry to 'stabilize society' amid racial injustice, economic downturnIn a tumultuous 2020, the COVID-19 pandemic and simmering racial protests have exposed gaps between the ideal America some of its citizens see and the real America on the ground. Few voices have capt2020/10/19
-
Gilead's remdesivir has 'little or no effect' on COVID-19 recovery or mortality: WHOGilead Sciences’ antiviral remdesivir got an emergency authorization from the FDA to treat COVID-19 in May on the basis of a study showing the drug cut the recovery time for hospitalized patients by2020/10/16
-
Roche hit by 'high-end' biosimilar attack as Ocrevus, Tecentriq bounce back from COVID-19 slowdownBiosimilars historically haven't enjoyed the same success in the U.S. asin Europe. So industry watchers weren’t exactly sure how copycats to Roche’s big three cancer drugs—Avastin, Rituxan and Hercep2020/10/15
-
DNA maker Touchlight adds Lonza manufacturing vet as it swings at COVID-19 vaccine, cell and gene therapy marketsWith dozens of approvals expected in the coming years, the cell and gene therapy space has turned into a goldmine for contract manufacturers. But COVID-19 vaccines are also a potentially lucrative bu2020/10/15
-
Thermo Fisher will add 2 new filling lines to global expansion plans with $130M Singapore plantWith global expansion plans underway, New Jersey contract manufacturer Thermo Fisher Scientific has signed some big checks in recent years to support its ambitious aims. Now, the company is set to bu2020/10/14
-
Did oral COVID-19 vaccine maker Vaxart exaggerate Warp Speed role to benefit insiders? DOJ wants to find outOn Tuesday, California biotech Vaxart unveiled that it haddosedthe first subject in a phase 1 study of its oral tablet COVID-19 vaccine candidate. But the good news was clouded with investigations an2020/10/14
-
Cytiva tasked with COVID-19 vaccine work as part of $31M U.S. government grantWith the U.S. working at a rapid clip to scale capacity for a range of COVID-19 vaccines and therapeutics, stateside companies are snagging big down payments on the taxpayers' dime. Now, the governme2020/10/13
-
Hey investors, COVID-19 vaccine manufacturing partner Emergent won't suffer from AZ, J&J trial holds: analystsShares of Emergent BioSolutions have been on a roller coaster of late, plummeting last month when customer AstraZeneca had to put its COVID-19 vaccine trial on hold, then taking a beating again yeste2020/10/13
-
J&J's immunology meds Stelara, Tremfya posted big revenue gains, but pricing is slipping: analystJohnson & Johnson touted solid growth for its immunology meds Stelara and Tremfya in its latest quarterly results,butBernstein analysts are spotlighting steep net pricing declines for the meds am2020/10/12
-
No need to panic about COVID-19 trial halts, FDA chief says. They show the system is workingHeadlines about COVID-19 vaccine and drug trial pauses may ring alarm bells for millions of people watching their progress, but FDA Commissioner Stephen Hahn, M.D., has another point of view. The bre2020/10/12